A prospective, single-masked, comparative study to compare the effect of Omidria (phenylephrine and ketorolac 1.0%/0.3%) vs epinephrine on pain reduction and opioid usage during cataract surgery
Latest Information Update: 21 Nov 2019
At a glance
- Drugs Ketorolac/phenylephrine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
Most Recent Events
- 12 Nov 2019 According to an Omeros Corporation media release, Eric D. Donnenfeld, M.D., (Clinical Professor of Ophthalmology at New York University) is the study investigator.
- 09 Nov 2019 Results published in the Clinical Ophthalmology
- 09 Nov 2019 New trial record